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Abstract
More effective treatment of metastasizing osteosarcoma with a current mean 5-year survival rate of less than 20%
requires more detailed knowledge on mechanisms and key regulatory molecules of the complex metastatic process.
CXCR4, the receptor of the chemokine CXCL12, has been reported to promote tumor progression and metastasis in
osteosarcoma. CXCR7 is a recently deorphanized CXCL12-scavenging receptor with so far not well-defined
functions in tumor biology. The present study focused on a potential malignancy enhancing function of CXCR7 in
interaction with CXCR4 in osteosarcoma, which was investigated in an intratibial osteosarcoma model in SCID mice,
making use of the human 143B osteosarcoma cell line that spontaneously metastasizes to the lung and expresses
endogenous CXCR4. 143B osteosarcoma cells stably expressing LacZ (143B-LacZ cells) were retrovirally
transduced with a gene encoding HA-tagged CXCR7 (143B-LacZ-X7-HA cells). 143B-LacZ-X7-HA cells co-
expressing CXCR7 and CXCR4 exhibited CXCL12 scavenging and enhanced adhesion to IL-1β-activated HUVEC
cells compared to 143B-LacZ cells expressing CXCR4 alone. SCID mice intratibially injected with 143B-LacZ-X7-HA
cells had significantly (p<0.05) smaller primary tumors, but significantly (p<0.05) higher numbers of lung metastases
than mice injected with 143B-LacZ cells. Unexpectedly, 143B-LacZ-X7-HA cells, unlike 143B-LacZ cells, also
metastasized with high incidence to the auriculum cordis. In conclusion, expression of the CXCL12 scavenging
receptor CXCR7 in the CXCR4-expressing human 143B osteosarcoma cell line enhances its metastatic activity in
intratibial primary tumors in SCID mice that predominantly metastasize to the lung and thereby closely mimic the
human disease. These findings point to CXCR7 as a target, complementary to previously proposed CXCR4, for more
effective metastasis-suppressive treatment in osteosarcoma.
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Introduction
Osteosarcoma (OS) is the most common primary bone tumor
in young adolescents [1]. It occurs with an incidence of
approximately 3 cases per million people per year. The survival
of OS patients undergoing surgery and radiotherapy alone is
poor [2]. Multi-agent chemotherapy increased the 5-year
overall survival of patients with localized disease to between 60
and 70% [3]. The survival of patients with metastatic disease,
however, remains poor with survival rates ranging from 11 to
20%. Thus, metastasis is the major cause of death in OS [4,5].
Metastasis is a complex multistep process. Tumor cells need
to be programmed for local tissue invasion, intravasation,
survival in the circulation, migration to and extravasation in
secondary organs and finally colonization in the metastatic
niche [6]. Tumor cell migration from the primary tumor to
secondary organs (tumor cell homing) is frequently guided by
chemokines. This has been well documented in breast cancer
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for the chemokine CXCL12 that, through interaction with its
receptor CXCR4 in metastasizing tumor cells, directs their
homing to the metastatic site [7,8]. In OS, CXCL12 interacting
with CXCR4 was shown to drive tumor progression and
metastasis [9,10]. Recently, CXCR7 was deorphanized as a
second receptor with high affinity for CXCL12 [11]. CXCR7 was
found to be expressed in hematopoietic cells where it functions
as scavenger receptor shaping CXCL12 gradients, which in
turn enable cell migration mediated by CXCR4 [12]. It was also
recognized in many tumor cell lines and in activated endothelial
cells [11]. This suggested that CXCR7, like CXCR4, might play
a role in immune-regulation, angiogenesis and adhesion to
endothelial cells. Interestingly, a number of studies that
investigated potential roles of CXCR7 in tumor biology revealed
malignancy-enhancing properties of the receptor in different
tumor types. Over-expression of CXCR7 in breast cancer cells
promoted growth and survival and enhanced adhesion to
interleukin-activated HUVEC cells [11,13]. In vivo, these breast
cancer cells, stably expressing CXCR7, formed larger primary
tumors than CXCR7-negative control cells. Furthermore, in an
experimental metastasis model of breast cancer, forced
expression of CXCR7 enhanced metastatic seeding and
proliferation in the lung [14]. These observations were in good
agreement with the results of a study investigating patients with
breast cancer. This study revealed an inverse correlation
between CXCR7 expression in tumor tissue and overall patient
survival, suggesting that CXCR7 contributed to a more
aggressive tumor phenotype. A tumor and metastasis
promoting function of CXCR7 was also described in prostate
and lung cancer [14,15]. In rhabdomyosarcoma, shown to
employ CXCR4-mediated mechanisms [16,17], ectopic
expression of CXCR7 in rhabdomyosarcoma cells enhanced
their metastatic potential in experimental metastasis revealed
by intravenous tumor cell injection. Furthermore, in Ewing’s
sarcoma, up-regulated expression of CXCR4 in tumor tissue
specimens was found associated with a high propensity for
metastasis and the expression of CXCR7 was an indicator for
poor patient survival [16–18]. These findings suggest
synergistic malignancy-enhancing actions of CXCR4 and
CXCR7 in cancer development. Furthermore, CXCR4-targeting
metastasis suppressive treatment strategies with CXCR4
antagonists in experimental metastasis models of OS and in a
wide range of other cancer metastasis models were only
partially successful [9,19,20].
In view of so far non-existing data on the role of CXCR7 in
interaction with the reported tumor and metastasis-promoting
actions of the CXCL12/CXCR4 axis in OS [9,10], we
investigated in the present study the biological relevance of
CXCR7 in a metastasizing intratibial human xenograft OS
model in SCID mice that makes use of the human CXCR4-
expressing 143B cell line and closely mimics the human
disease with metastasis to the lung. The study monitored
intratibial primary tumor growth over time and lung metastasis
at sacrifice of mice, which were intratibially injected with LacZ
gene transduced 143B cells that had been superinfected with
an empty retroviral vector (143B-LacZ-EV cells) (control) or
with the same vector encoding HA-tagged CXCR7 (143B-LacZ-
HA-X7 cells). X-gal staining of LacZ-expressing 143B cells in
tissues dissected from mice at sacrifice allowed the detection
of single tumor cells. CXCR7 function in 143B-LacZ-HA-X7
cells was examined in a CXCL12-scavenging assay and in vitro
metastatic properties by adhesion to IL-1β-stimulated HUVEC.
Results
Expression of HA-CXCR7 in 143B-LacZ cells mediates
CXCL12 scavenging and enhances adhesion to HUVEC.
The expression of HA-CXCR7 was verified by semi-
quantitative RT-PCR of total RNA extracted from 143B-LacZ-
EV and 143B-LacZ-HA-X7 cells (Figure 1A) and by FACS of
the cell lines immunostained for HA-CXCR7 cell-surface
expression (Figure 1B). Importantly, the expression of CXCR4
in 143B-LacZ cells was not affected by the overexpression of
HA-CXCR7 as demonstrated by FACS analysis (Figure 1C).
The mean CXCR4-related fluorescence intensity of 143B-LacZ-
HA-X7 and of 143B-LacZ-EV cells was 859 ± 90 (SEM) and
870 ± 98 (SEM), respectively.
Ligand scavenging by CXCR7 was investigated in 143B-
LacZ-EV and 143B-LacZ-HA-X7 cells with three different
ligands fused to the fluorescent protein Venus. These ligands
included CXCL12-Venus, the competitive CXCR4 antagonist
P2G-CXCL12-Venus and chimeric CXCL11/CXCL12-Venus
(Figure 1A) [21]. CXCL11 is a second high-affinity ligand of
CXCR7 [30]. Time-dependent uptake of the three ligands was
only observed in 143B-LacZ-HA-X7 cells, but not in 143B-
LacZ-EV cells lacking CXCR7 (Figure 2A, B and movie S1
“CXCL12 -Venus uptake in 143B cells transduced with CXCR7”
and movie S2 “CXCL12-Venus uptake transduced with an
empty vector construct”, supporting information). Incubation of
143B-LacZ-HA-X7 cells with increasing concentrations of
CXCL12, on the other hand, reduced the density of HA-CXCR7
detected by FACS at the cell surface only minimally (Figure
2C). Taken together, both observations are consistent with
reported rapid cycling of HA-CXCR7 between the plasma
membrane and endosomal structures [12]. P2G-CXCL12-
Venus and CXCL11/CXCL12-Venus were found to be
internalized by CXCR7, but it was barely visible in cells that
expressed CXCR4 alone. In previous report it was shown [12]
that CXCR4 scavenging activity is weak and is probably a
consequence of the stoichiometric uptake and degradation with
the receptor, whereas CXCR7 can undergo multiple rounds of
ligand uptake leading to a marked uptake over time (Figure
2B). Moreover, it has been reported that CXCL12 binds to
CXCR7 with a 10x higher affinity (KD~0.2-0.4 nM) than to
CXCR4 (KD~2-4 nM) [11,22,23]. Thus, all these parameters
together result in CXCR7-mediated ligand internalisation that
largely predominates that of CXCR4 under the experimental
conditions used in this study.
The effect of CXCR7 overexpression in 143B-LacZ cells on
adhesion to endothelial cells was studied with non-stimulated
and IL-1β-stimulated HUVEC. The adhesion of 143B-LacZ-
HA-X7 cells to non-stimulated HUVEC was the same as that of
control 143B-LacZ-EV cells (Figure 2D). IL-1β stimulated the
adhesion of both cell lines to HUVEC (p<0.05), but, importantly,
143B-LacZ-HA-X7 adhered to IL-1β stimulated HUVEC
significantly better than 143B-LacZ-EV cells (p<0.05).
CXCR7 Promotes Lung Metastasis in Osteosarcoma
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Figure 1.  Overexpression of HA-CXCR7 in human OS 143B-LacZ cells.  (A) Semi-quantitative RT-PCR analysis showed non-
detectable expression of CXCR7 in 143B-LacZ-EV (EV) cells and abundant HA-CXCR7 (HA-X7) expression in 143B-LacZ-HA-X7
cells. GAPDH was used as reference gene. (B) FACS analysis showed HA-CXCR7 cell surface expression in HA-immunostained
(blue profiles) 143B-LacZ-HA-X7 cells, which was not observed in 143B-LacZ-EV (EV) cells. Red profiles were obtained in the
absence of HA antibody (n≥3). (C) FACS analysis with 12G5 antibody showed comparable CXCR4 surface expression in 143B-
LacZ-EV and 143B-LacZ-HA-X7 cells (blue profiles), confirming that the overexpression of CXCR7 did not alter the endogenous
levels of CXCR4. Red profiles indicate cells that were analyzed in the absence of 12G5 antibody (n=2).
doi: 10.1371/journal.pone.0074045.g001
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Figure 2.  HA-CXCR7 overexpression in 143B OS cells enhanced CXCL12 scavenging and adhesion to HUVEC.  (A) FACS
analysis showed efficient scavenging of fluorescent Venus-tagged CXCL12 (orange profile), CXCL12 antagonist P2G (green profile)
and chimeric CXCL11-CXCL12 (blue profile) in 143B-LacZ-HA-X7 (HA-X7), but not in control 143B-LacZ-EV (EV) cells. Controls in
the absence of fluorescent ligands (red profiles). (B) Time-dependent uptake of CXCL12-Venus by 143B-LacZ-HA-X7 (○), assessed
by time-laps confocal microscopy was not observed in 143B-LacZ-EV (●) cells. (C) CXCL12 at indicated increasing concentrations
provoked minimal loss of HA-CXCR7 at the surface of 143B-LacZ-HA-X7 analyzed by FACS. (D) 143B-LacZ-HA-X7 (HA-X7) cells
exhibited enhanced adhesion to interleukin-1β activated HUVEC compared to 143B-LacZ-EV cells. #,Ω,Δ indicate significant
differences (p<0.05) between indicated cell lines and conditions. Values represent the mean ± SEM (n=3).
doi: 10.1371/journal.pone.0074045.g002
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Taken together, enhanced CXCL12 scavenging and
adhesion to HUVEC indicated functional CXCR7 expression in
143B-LacZ-HA-X7 cells. These findings set the stage for an in
vivo study that investigated in the 143B-LacZ cell line-derived
metastasizing intratibial OS model in SCID mice a potential
malignancy-enhancing function of CXCR7 in CXCR4
expressing OS.
CXCR7 overexpression in 143B-LacZ cells diminishes
intratibial primary tumor growth, but promotes lung
and auriculum cordis metastases in SCID mice
Forced expression of HA-CXCR7 in intratibial primary tumors
derived from 143B-LacZ-HA-X7 cells was confirmed by HA and
CXCR7 immunostaining of sagittal paraffin-sections of the
tumor-bearing tibia (Figure 3A and Figure S1A). Importantly,
the expression pattern of CXCR7 in 143B-LacZ-EV and 143B-
LacZ-HA-X7 cell-derived tumors was indistinguishable from
that observed in the respective cells in vitro, with non-
detectable CXCR7 expression in 143B-LacZ-EV cell-derived
tumors and robust expression in 143B-LacZ-HA-X7 cell-derived
tumor tissue (Figure S1A). Moreover, the expression pattern of
CXCR4 observed in vivo was also comparable to that observed
in 143B-LacZ-EV and 143B-LacZ-HA-X7 cells in vitro,
indicating that the in vivo environment did not alter the
expression of endogenous CXCR4 in the two cell lines (Figure
S1B).
Remarkably, SCID mice injected with 143B-LacZ-HA-X7
cells developed within 27 days smaller (p<0.05) intratibial
primary tumors than the mice injected with the control 143B
LacZ-EV cells (Figure 3A and Table 1). However, 143B-LacZ-
HA-X7 cell-injected mice had significantly (p<0.05) higher
numbers of X-gal-stained lung metastases than the control
143B-LacZ-EV cell-injected animals (Figure 3B and Table 1).
Moreover, rare metastases in the auriculum cordis were
observed in only 14% of the 143B-LacZ-EV cell-injected SCID
mice and surprisingly in 83% of the 143B-LacZ-HA-X7 cell-
injected animals (Figure 3C and Table 1). This unexpected
finding prompted a detailed immunohistochemical analysis of
the auriculum cordis and of the lung for expression of
endogenous CXCL12 as a chemo-attractant for CXCR4 and
even more for CXCR4/CXCR7 co-expressing tumor cells.
Immunohistochemistry identified CXCL12 in lung
peribronchial tissue and in heart vessels next to the
auriculum cordis
Hematoxylin and eosin staining and HA immunostaining of
tissue sections of the auriculum cordis confirmed the
pronounced infiltration of the organ by 143B-LacZ-HA-X7 cells,
whereas metastatic lesions remained largely undetectable in
the tissue of SCID mice with 143B-LacZ- EV cell-derived
primary tumors (Figure 4). The combined histological and
immunohistochemical analysis confirmed the findings of the X-
gal staining of lung and auriculum cordis whole mounts (Figure
3B, C) Interestingly, sections of the myocardia of 143B-LacZ-
EV cell- and 143B-LacZ-HA-X7 cell-injected mice showed no
metastatic lesions, suggesting rather selective homing of the
cells to the auriculum cordis.
Immunohistochemical staining of lung and heart tissue
sections for CXCL12 localized the chemokine in peribronchial
tissue and in heart vessels in the proximity of the auriculum
cordis (Figure 4B) thereby confirming that lung tissue is a
rather rich source of CXCL12. Somewhat surprisingly, CXCL12
remained undetectable in the auriculum cordis of all SCID mice
investigated here.
Discussion
The CXCL12/CXCR4 axis was shown to be involved in tumor
development and metastatic spread of many cancer types,
including OS [7,9,19,24]. Furthermore, there is emerging
evidence for important functions of CXCR7, a recently
deorphanized second CXCL12 receptor, in cancer progression
and metastasis of different tumor types including those of
mesenchymal origin [14–17,25].
The present study focused on the biological relevance of
CXCR7 in OS in interaction with the CXCR4/CXCL12 axis,
reported to promote primary tumor growth and metastasis
[9,10]. Previous studies in other tumor types suggested a
malignancy-enhancing activity of CXCR7 even in the absence
of CXCR4 [14,15,25]. The results of this study in the intratibial,
spontaneously metastasizing OS model in SCID mice
confirmed a malignancy enhancing activity of CXCR7 in
CXCR4-expressing OS, reflected by more aggressive
metastasis to the lung and surprisingly also to the auriculum
cordis. Interestingly and surprisingly, forced expression of
CXCR7 in the here used intratibial OS xenograft model not only
promoted metastasis, but it also diminished primary tumor
growth. All these findings suggest that CXCR7 might facilitate
extravasation of metastasizing OS cells from the primary tumor
site, which is also consistent with the observed remarkable
increase in the number of metastases in distant organs. This
interpretation of our observation is in good agreement with
conclusions of previous studies with CXCR4 and CD34
expressing hematopoietic stem cells (HSC) [26]. These studies
showed that CXCL12, produced at high levels in bone marrow,
caused retention of HSC in distinct compartments.
Administration of the CXCR4 antagonist AMD 3100 reversed
this observation and led to a release of HSC progenitor cells
from the bone marrow and fast generalized leukocytosis,
Table 1. Total number of mice per experimental group and
characteristics of primary tumors and metastatic spread.
 143B-LacZ-EV  
143B-LacZ-HA-
X7
Number of mice 6  7
Tumour volume (median in mm3) 130.5  15.36
Tumour volume (mean ± SEM in mm3) 107.2 ± 27.13  17.75 ± 3.08
Number of lung metastatic foci per lung
lobe (mean ± SEM) 1.5 ± 0.48  26.67 ± 12.8
Percentage of mice with metastases in the
auriculum cordis (mean ± SEM) 14.29 ± 14.29  83.3 ± 16.67
SEM: standard error of the mean
doi: 10.1371/journal.pone.0074045.t001
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Figure 3.  Overexpression of HA-CXCR7 in 143B-LacZ cells diminished primary intratibial tumor growth, but promoted
metastasis to the lung and the auriculum cordis.  (A) Representative X-ray images of a tumor cell injected leg (tumor leg) and of
the contralateral non-injected leg (control leg) of mice injected with 143B-LacZ-EV (EV) cells or with 143B-LacZ-HA-X7 (HA-X7)
cells at day 27 after tumor cell injection and representative HA immunohistochemical staining of HA-CXCR7 on sagittal sections of
EV and HA-X7 cell injected tibiae and mean calculated volume of intratibial tumors in EV and HA-X7 cell-injected mice at day 27
after tumor cell injection. (B) Representative lung whole mounts with X-gal-stained metastases (blue) obtained from EV (arrows
indicate the metastases) and HA-X7 cell injected mice and mean (± SEM) numbers of metastases on the lung surface of respective
animals. (C) Whole mounts of auriculum cordis enlarged from (B) with X-gal stained metastatic lesions and mean (± SEM)
percentage of mice in indicated groups with auriculum cordis metastatic lesions. Six and 7 mice in the EV and the HA-X7 groups,
respectively, were analyzed. *p≤0.05.
doi: 10.1371/journal.pone.0074045.g003
CXCR7 Promotes Lung Metastasis in Osteosarcoma
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demonstrating the importance of CXCL12 as a retention signal
for HSC in the bone [27–29]. In addition, efficient CXCL12
scavenging by 143B-LacZ-HA-X7 cells shown in vitro may at
the primary tumor site also diminish CXCR4-mediated tumor
growth promoting activity of CXCL12 in the human 143B OS
cell line. Growth-stimulating activity of CXCL12 has been
reported in previous studies in other OS cell lines [9,10].
Contrasting findings of Wang and co-workers who
demonstrated that expression of CXCR7 in a CXCR4
background in prostate cancer led to faster primary tumor
growth [15,30] suggest that growth regulating functions of
Figure 4.  Histology and immunostaining of paraffin sections showed a lower metastatic load in the auriculum cordis and
the lung of 143B-LacZ- EV than of 143B-LacZ-HA-X7 cell-injected mice and expression of CXCL12 in both tissues.  (A)
Representative H&E staining of sections of indicated tissues collected from 143B-LacZ-EV (EV) and 143B-LacZ-HA-X7 (HA-X7) cell
injected mice. (B) X-gal (blue) and HA immunostaining of metastatic lesions and immunohistochemical localization of CXCL12 in
large vessels of the heart base (hv) region and in lung vessels (lv) and in peribronchial tissue (pbt) of representative paraffin
sections of indicated tissues collected from EV and HA-X7 cell-injected mice. (C) Control staining of indicated tissues in the absence
of primary HA antibodies. Size bars: 50 µm.
doi: 10.1371/journal.pone.0074045.g004
CXCR7 Promotes Lung Metastasis in Osteosarcoma
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CXCL12 may depend on tumor cell origin and on the tumor
environment.
The characterization of CXCR7-overexpressing 143B cells in
vitro revealed increased adhesion to HUVEC and confirmed
reported observations in CXCR7 transduced breast cancer
cells [11,31]. Based on recently published findings of Zabel and
co-workers, who demonstrated that CXCR4/CXCR7 co-
expressing lymphoblastic tumor cells exhibited significantly
enhanced trans-endothelial migration compared to cells
expressing CXCR4 alone [13,31]. We believe that enhanced
adhesion of CXCR7 overexpressing 143B cells to lung
endothelium leads to more frequent successful trans-
endothelial migration and, consequently, to the observed
higher number of lung metastatic foci. Thus, the combination of
facilitated extravasation of CXCR7 overexpressing 143B cells
from the intratibial injection site into the bloodstream, due to
enforced local CXCL12 scavenging, and more effective
adhesion/TEM at the vasculature/lung interface likely explains
the enhanced metastatic potential of CXCR7 overexpressing
compared to control 143B cells that resulted in the observed
significant increase in the number of lung metastases.
The high incidence of remarkably large metastatic lesions in
the auriculum cordis of SCID mice with CXCR7 overexpressing
primary tumors compared to 143B control cell-injected animals
was an unexpected finding, because, as mentioned before,
CXCL12 remained undetectable in this tissue. However,
CXCL12 was found expressed in heart vessels in close
proximity to the auriculum cordis. Along these lines, the results
of a recently reported study showed that CXCR7 enhanced
CXCL12/CXCR4-mediated trans-endothelial migration of tumor
cells [31]. Moreover, another study demonstrated that CXCL12-
evoked chemotaxis of CXCR4 expressing HOS cells to
fibronectin was mediated by α4β1 and α5β1 integrins [32] and
that intradermal tumors shrunk in response to treatment with
α5β1 antibodies. We therefore hypothesize that the here
observed metastasis of the HOS cell-derived 143B cells to the
auriculum cordis, shown to be enhanced by forced expression
of CXCR7, may be also mediated by integrins interacting with
extracellular matrix characteristic for this tissue. However, we
speculate that the massive metastatic load of CXCR7
overexpressing 143B cells to the auriculum cordis is specific to
this OS mouse model because metastasis to this organ has, to
our knowledge, so far not been reported for OS patients
[33–36].
In conclusion, the results of the present study demonstrate
that forced expression of the recently de-orphanized CXCL12-
scavenging receptor CXCR7 in the human metastatic CXCR4-
expressing 143B OS cell line remarkably enhances its
metastatic phenotype in vitro and in vivo. These findings
obtained in an experimental OS model, which closely mimics
the human disease, suggest that co-expression of CXCR4 and
CXCR7 is also a metastasis-enhancing principle in the human
disease that needs to be further investigated. Along these
lines, the results of a recent preliminary immunohistochemical
analysis of a limited number of human OS tissue specimens,
carried out in our laboratory, indicated a tendency for worse
survival of patients with tumors that co-expressed CXCR4 and
-7 compared to patients with tumors that expressed none of the
receptors. However, co-expression of CXCR4 and CXCR7 in
OS tumor tissue did not change the predictive power for a
tendency of poor outcome that was also already evident when
CXCR4 immunostaining was analyzed alone. Nevertheless,
this analysis needs to be extended to a larger patient cohort
that will allow a meaningful statistical analysis. All observations
of the present study taken together suggest that OS treatment
that targets both CXCR7 and CXCR4 will likely be more
effective than so far reported attempts to inhibit OS progression
and metastasis in experimental OS animal models by blocking
CXCR4 alone [20].
Materials and Methods
Cell lines
143B cells were purchased from the European Collection of
Cell Cultures (Salisbury, UK). Cells were grown in Dulbecco’s
modified Eagle medium (DMEM) (4.5g/L glucose) and Ham
F12 (F12) medium (1:1) supplemented with 2 mM L-glutamine
(PAA GmbH, Germany), 10% heat-inactivated fetal calf serum
(FCS) (GIBCO, Basel, Switzerland). The cells were kept in a
humidified atmosphere of 95% air and 5% CO2 at 37°C.
RNA isolation and RT-PCR
Total RNA was isolated from cell lines with TriReagent
(Sigma-Aldrich, St. Louis, MO) as described recently [37]. The
RNA was quantified spectrophotometrically and the integrity of
the RNA was assessed by standard agarose gel-
electrophoresis. The expression of mRNA encoding CXCR7
was analyzed by RT-PCR and GAPDH transcripts were used
as a reference. cDNA was synthesized from 1 µg of total RNA
with the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Zug, Switzerland), using the protocol
recommended by the supplier. PCR reactions of 50 µl final
volume contained 1X PCR buffer, 0.4 µl of the reverse
transcription reaction, 1.25 U Taq polymerase (5Prime), 200
µM of each dNTP, and 0.2 µM of forward and reverse primer
pairs specific for the individual transcripts (GAPDH Forward:
TGA ACG GGA AGC TCA CTG GCA TGG; GAPDH Reverse:
TGG GTG TCG CTG TTG AAG TCA GAG GAG; CXCR7
Forward: 5’ GCA GAG CTC ACA GTT GTT GCA AAG’3;
CXCR7 Reverse: 5’ ATG AAG GAG AGC GTG TAG AGC
AGG’3) The cDNA was denatured at 94°C for 3 min, and then
amplified by 27 to 40 PCR cycles (denaturation at 94°C for 40
sec, primer pair- dependent annealing at 67°C to 69°C for 40
sec, and elongation at 72°C for 20 sec) followed by a final
elongation step at 72°C for 7 min. PCR products were analyzed
by agarose gel electrophoresis.
Retroviral transduction of 143B cells
143B cells were transduced with the LacZ gene (143B-LacZ
cells) using the pQCLIN retroviral expression vector (Clontech,
Paolo Alto, CA) as recently described for other OS cell lines
[38,39]. Subcloning of a HindIII-EcoRV fragment encoding
CXCR7 with an N-terminal HA- epitope tag (HA-X7) from a
pcDNA3.1 plasmid into the retroviral expression vector
pQCIXH containing a hygromycin resistance gene revealed
CXCR7 Promotes Lung Metastasis in Osteosarcoma
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pQCIXH-HA-X7. Retroviral particles with integrated pQCLIN-
LacZ (LacZ-retrovirus), pQCIXH (empty vector (EV)-retrovirus)
or pQCIXH-HA-X7 (HA-X7-retrovirus) were produced in
HEK293-T cells as reported [38].
143B-LacZ cells were infected with EV- (143B-LacZ-EV
cells) or HA-X7-retrovirus (143B-LacZ-X7-HA cells) with the
protocol that was used for LacZ-transduction of the 143B cells
and clones of 143B-LacZ-EV and 143B-LacZ-X7-HA cells were
selected in tissue culture medium containing 1 mg/ml
hygromycin (Merck, Zug, Switzerland). In order to further enrich
HA-X7 expressing 143B-LacZ cells, cells under hygromycin
selection were detached with 1xPBS, 0.05% EDTA and
resuspended in 1xPBS. They were then stained with 5µg/ml
primary HA antibodies (HA 2.11 Covance, Princeton, NJ) at
4°C for 30 min and with 5µg/ml secondary goat anti-mouse
IgG-PE (Invitrogen, Carlsbad, CA) at 4°C for 20 min.
Subsequently, they were filtered through a filter of 50 µm pore
size (Partec, Nunningen, Switzerland) and FACS sorting was
performed (FACS Aria, BD Biosciences, San Jose, CA) and
analyzed on a FACS machine (Calibur, BD, Franklin Lakes,
NJ). 143B-LacZ-EV cells as well as 143B-LacZ-HA-X7
enriched for HA-CXCR7 expression were further analyzed for
comparable expression of CXCR4. Both cell lines were stained
with 5µg/ml primary CXCR4 antibody (BD Bioscience, San
Jose, CA) directly coupled to the fluorochrome allophycocyanin
(APC) at 4°C for 30’ or with an isotype control antibody coupled
to APC (BD Bioscience, San Jose, CA) and then also analyzed
by FACS.
CXCR7-mediated ligand internalization examined by
time-laps confocal microscopy and by FACS analysis
Venus-fluorescent derivatives of CXCL12 (CXCL12-Venus),
its antagonist P2G (P2G-Venus) and of chimeric CXCL12/
CXCL11 (CXCL12/CXCL11-Venus) were obtained by fusion
with the fluorescent protein Venus and used for ligand
internalization experiments. They were produced with a
baculovirus expression system in the insect cell line High-5
(Invitrogen, Carlsbad, CA) that was grown in protein-free
medium. The fusion proteins were purified by ion-exchange
and gel filtration chromatography. The fluorescent ligands were
stored in stock solutions at 5 µM concentrations.
Uptake of recombinant CXCL12-Venus by 143B-LacZ-HA-X7
and 143B-LacZ-EV cells was examined by time-laps confocal
microscopy as follows: cells were detached with trypsin/EDTA
and resuspended in tissue culture medium at a final density of
3-4 x 106 cells/ml. 200 µl of the suspension were seeded on a
glass bottom petri dish and allowed to adhere overnight. Cells
in 150 µl fresh tissue culture medium containing 1x EDTA-free
protease inhibitors were placed on a stage of a confocal
microscope (Leica SP5) equipped with a humidified chamber
and equilibrated at 37°C (Life Imaging Services, Basel,
Switzerland). A z-stack (0 time point) was recorded during 15
min of pre-incubation. The medium was then replaced by 150
µl of fresh tissue culture medium containing 30 nM CXCL12-
Venus. Z-stacks were recorded every 2 min during 22 min. For
each time point, planes corresponding to the center of the cells,
excluding surface and bottom areas were collapsed and the
fluorescence intensities above threshold of the YFP channels
(CXCL12-venus) calculated with Metamorph software
(Molecular Devices GmbH, Biberach an der Riss, Germany).
For FACS analysis of ligand internalization, 143B-LacZ-EV
and 143B-LacZ-HA-X7 cells were detached with trypsin/
ethylenediaminetetraacetic acid (EDTA) and resuspended in
FACS buffer (1xPBS/0.05% EDTA/1% BSA). 200 µl of this
suspension, with a density of 1 x106 cells/ml, were used for
individual experiments with the different Venus-fluorescent
ligands. The cells were transferred to a 96 well plate, harvested
by centrifugation and resuspended in FACS buffer containing
the indicated Venus-fluorescent ligands. The cells were
incubated at 37°C for 30 min and cells incubated on ice were
used as a control. Uptake was stopped by centrifugation at 4°C
for 2 min and ligand bound to CXCR7 at the cell surface was
removed by a brief acidic wash with 150 mM NaCl, 50 mM
glycine, pH 3. Internalized ligand was then quantified by FACS
analysis.
Agonist stimulated receptor internalization
143B-LacZ-HA-X7 cells were incubated with 0, 1, 10 or 100
nM CXCL12 and incubated at 37°C for 30 min. Cells were then
subjected to an acidic wash (see above) to remove surface
bound ligand. Receptors remaining localized at the cell surface
were immunostained with CXCR7 antibodies [40] and Alexa
Fluor 488-F(ab’) goat anti-mouse IgG (Invitrogen, Carlsbad,
CA) and the cells subsequently sorted by FACS.
Adhesion to endothelial cells
Human umbilical vein endothelial HUVECs cells were kindly
provided by Dr. S.P. Hoerstrup, Swiss Center for Regenerative
Medicine (SCRM), University Hospital, Zurich (License Number
STV1-2005 approved by the local Ethics Committee) [41].
HUVECs were cultured in EGM-2 MV medium (Lonza, Basel,
Switzerland) and seeded into 96-well plates (35’000/well) 24 h
before the adhesion assay. 143B-LacZ-EV and 143B-LacZ-HA-
X7 cells were labeled with Vybrant® Dil (Invitrogen, Carlsbad,
CA) and reseeded in cell culture flasks. Adhesion to HUVEC
was assessed in three independent experiments in triplicate
wells for each condition and cell line. Briefly, labeled 143B-
LacZ-EV and 143B-LacZ-HA-X7 cells grown in the cell culture
flasks were detached and 104 cells were added to untreated or
IL-1β stimulated (1 nM, 6 h) HUVECs. 143B-LacZ-EV and
143B-LacZ-HA-X7 cells were then allowed to adhere at 37°C
for 15 min in the absence of IL-1β. Non-adherent cells were
removed by shaking the plates, and the wells were washed
twice with PBS and fixed with 4% formalin at RT for 10 min.
Adherent fluorescent cells were viewed with a Zeiss Observer.
Z1 microscope equipped with appropriate fluorescence filter
and counted with ImageJ software. The mean numbers of
adhering cells of the individual cell lines at indicated conditions
were calculated from the number of adhering cells counted in
areas of 3.6 mm2 in respective wells (12% of total well area).
The results of the three independent experiments are
presented as per cent of adherent cells compared to seeded
cells.
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Intratibial OS model in SCID mice
Female 6-8 week old immunosuppressed SCID mice were
purchased from Charles River Laboratories (Sulzfeld,
Germany) at least 7 days prior to experimental
commencement. Housing conditions and experimental
protocols were in accordance with institutional guidelines
approved by the Ethics Committee of the Veterinary
Department, Canton of Zurich, Switzerland (License Number
129/2009). The mice were housed in groups of 5 animals in
individual ventilated 32 x 16 cm cages at room temperature.
143B-LacZ-EV and 143B-LacZ-HA-X7 cells were grown to
subconfluency, detached with Trypsin/EDTA/PBS and
resuspended in PBS/0.05% EDTA at a final density of 5x107
cells/ml. Ten microliters of the cell suspension (5x105 cells)
were orthotopically injected into the medullar cavity of the left
tibia of the mice. Tumor growth and osteolysis were examined
by X-ray (Faxitron X-Ray Corporation, Lincolnshire, IL) once a
week. The tumor volume was calculated from caliper rule
measurements with the following formulas: leg volume = length
x (width)2 x 0.5; tumor volume = leg volume on day X – leg
volume leg on injection day 0; (X= 0,7,14,21 and 27 days).
Organs were prepared as described previously [39]. The group
of mice injected with 143B-LacZ-EV cells consisted of 6
animals and that injected with 143B-LacZ-HA-X7 cells of 7
animals. All mice in both groups developed intratibial primary
tumors and metastases in the lung.
All mice were sacrificed on day 27. Lungs were prepared as
described by Arlt et al. [38] and LacZ expressing metastatic
tumor cells were visualized by X-Gal staining as described [42].
Briefly, lung tissue was refixed with 2% formaldehyde and 0.2%
glutaraldehyde in PBS at room temperature for 1 h, washed 3-
times with PBS and then stained in X-Gal staining solution at
37°C for at least 3 h. Metastases, defined as indigo-blue
stained foci >0.1 mm in diameter on the surface of whole-
mounts of lungs, were counted.
Immunohistochemistry of mouse tissue
Heart, lung and legs were fixed with 4% paraformaldehyde
and embedded in paraffin. Sections of 3-6µm were
deparaffinized, rehydrated, counterstained in hematoxylin and
washed with tap water. Subsequently, the sections were
incubated with antibodies to the HA-tag of CXCR7 (Covance,
Princeton, NJ), to CXCR7 (Proteintech, Chicago, IL), to CXCR4
(R&D Systems, Minneapolis, MN) to CXCL12 (K15C, kind gift
of F. Arenzana-Seidedos, Paris). EnVision-method (DAKO,
Glostrup, Denmark) was applied according to the
manufacturer’s instructions and the peroxidase substrate AEC
(Invitrogen, Carlsbad, CA) was used as a chromogen to
visualize tissue staining.
Statistical analyses
Results are presented as mean ± standard error of the mean
(SEM). The data obtained from the experiments that assessed
the adhesion to non-stimulated and IL-1β stimulated HUVEC
cells were analyzed with one-way ANOVA (Bonferroni test).
The values of primary tumor volume and the number of
metastases were analyzed by the unpaired Student’s t-test or
by Mann-Whitney-test with GraphPad Prism® 5.01 software.
Supporting Information
Figure S1.  Immunostaining of paraffin sections confirmed
overexpression of CXCR7 in the primary tumor of mice
injected with 143B-LacZ-HA-X7 cells compared to the
group injected with 143B-LacZ-EV whereas CXCR4 levels
were comparable. (A) Representative images of CXCR7
staining on primary tumor tissue from 143B-LacZ-EV (EV) and
143B-LacZ-HA-X7 (HA-X7) cell injected mice. (B)
Representative images of CXCR4 staining on primary tumor
tissue from 143B-LacZ-EV (EV) and 143B-LacZ-HA-X7 (HA-
X7) cell injected mice. In panels A and B negative controls
show images of sections of primary tumors stained with the
secondary antibody alone. Size bars: 50 µm.
(TIF)
Movie S1.  143B-LacZ-HA-X7 cells demonstrate efficient
uptake of CXCL12 –Venus compared to 143B-LacZ-EV
cells due to the scavenging activity of CXCR7 (S1). Video
showing time-dependent uptake of CXCL12 –Venus by 143B-
LacZ-HA-X7 cells (S2). Video showing a very weak time-
dependent uptake of CXCL12 –Venus by 143B-LacZ-EV cells.
(AVI)
Movie S2.  Video showing time-dependent uptake of
CXCL12 –Venus by 143B-LacZ-HA-X7 cells. (S2) Video
showing a very weak time-dependent uptake of CXCL12 –
Venus by 143B-LacZ-EV cells.
(AVI)
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